The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Therastat
Cherry Cough Drops · MENTHOL 5.8 mg/1 · Lozenge · Oral · HART Health
NDC 50332-0137-04 · 50 PACKET in 1 BOX / 1 LOZENGE in 1 PACKET · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cherry Cough Drops (Lozenge)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Chain Drug Marketing Association, Inc. | MENTHOL 5.8 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cintas Corporation | MENTHOL 7 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| HART Health | MENTHOL 5.8 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| HART Health | MENTHOL 7.6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Therastat — NDC 50332-0137-04," retrieved September 3, 2026, https://drugdashboards.com/drug/50332013704.
Free to cite with attribution — see how the data is put together.